Alpha-lipoic acid supplementation affects serum lipids in a dose and duration-dependent manner in different health status
An updated systematic review and dose-response meta-analysis of randomized controlled trials
Abstract
Abstract:Background: Many studies have investigated the effect of alpha-lipoic acid (ALA) supplementation on lipid profile, and different results have been obtained from these studies. The current systematic review and dose-response meta-analysis was conducted to achive a strong conclusion about the effect of ALA supplementation on lipid profile including total cholesterol (TC), low- and high-density lipoprotein cholesterol (LDL, HDL) and triglycerides (TG). Methods: A systematic search was performed in PubMed, SCOPUS, ProQuest and Embase for randomized placebo-controlled human trials that examined the effect of ALA supplementation on lipid profile up to November 2020. The dose and duration of ALA supplementation for included studies were ranged between 300–1200 mg/d and 2–16 weeks respectively. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were used to evaluate the effect size. Cochran’s Q and I2 tests were also used to assess between-study’s heterogeneity. In addition, subgroup analysis was performed to investigate potential sources of heterogeneity. Dose-response relationship was done using fractional polynomial modeling. Results: Among all eligible studies, 12 studies with a total number of 548 participants were selected. ALA caused a significant reduction on TC (WMD): −10.78 mg/dl, 95% CI: −20.81, −0.74, P=0.002), LDL (WMD: −10.88 mg/dl, 95% CI: −19.52, −2.24, P=0.014) and TG (WMD: −31.02 mg/dl, 95% CI: −49.63, −12.42, P<0.001). There was also a non-significant increaes in HDL concentrations. In addition, dose-response analysis showed a positive association between LDL (Pnon-linearity=0.026), TG (Pnon-linearity<0.001) and duration of intervention in a non-linear model. Conclusion: The present meta-analysis revealed the beneficial effects of ALA supplementation on TC, LDL and TG levels. Moreover, the beneficial effects of ALA supplementation on LDL and TG levels was duration-dependent.
References
1 . The link between the metabolic syndrome and cancer. Int J Biol Sci. 2011;7(7):1003–16.
2 . Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 2016;148:183–93.
3 . Managing the lipid profile of coronary heart disease patients. Expert Rev Cardiovasc. 2016;14(11):1263–71.
4 . An updated systematic review and dose-response meta-analysis of the effects of Alpha-Lipoic acid supplementation on glycemic markers in adults. Nutrition. 2020;111041–85.
5 . Alpha-lipoic acid supplementation significantly reduces the risk of obesity in an updated systematic review and dose response meta-analysis of randomised placebo-controlled clinical trials. Int J Clin Pract. 2020;74(6):e13493–e507.
6 Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with schizophrenia. Psychiatr Danub. 2014;26(3).
7 . Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 2015;93(12):1021–7.
8 The beneficial effects of alpha lipoic acid supplementation on Lp-PLA2 mass and its distribution between HDL and apoB-containing lipoproteins in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial. Oxid Med Cell Longev. 2020;2020:1–13.
9 . Does alpha-lipoic acid comsumption improve lipid profile in patients with stroke? A randomized, double blind, placebo-controlled clinical trial. Iran Red Crescent Med J. 2017;19(8):e58765–e71.
10 Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects. Obesity. 2011;19(8):1647–53.
11 Does saffron supplementation have favorable effects on liver function indicators? A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021:1–13.
12 . α-Lipoic acid therapy modulates serum levels of some trace elements and antioxidants in type 2 diabetic patients. Am J Pharmacol Toxicol. 2010;5(3):152–8.
13 . Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr. 2012;22(2):244–50.
14 . Effect of (R)-α-lipoic acid supplementation on serum lipids and antioxidative ability in patients with age-related macular degeneration. Ann Nutr Metab. 2012;60(4):293–7.
15 . The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Clin Endocrinol. 2008;68(5):716–23.
16 . Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus. J Clin Diagnostic Res. 2012;6(9):1469–73.
17 . The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Diabetes Res Clin Pract. 2011;92(2):253–60.
18 . Effects of R-alpha lipoic acid on HbA1c, lipids and blood pressure in Type-2 diabetics: A preliminary study. JCIM. 2009;6(1):1–16.
19 Impact of therapy with α-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr. 2009;49:129–33.
20 . Lipid lowering effect of ginseng and alpha-lipoic acid in hypercholesterolemic patients. Glob J Pharmacol. 2013;7(3):298–306.
21 Lipid lowering effect of antioxidant alpha-lipoic acid in experimental atherosclerosis. J Clin Biochem Nutr. 2008;43(2):88–94.
22 Macrophage-derived lipoprotein lipase increases aortic atherosclerosis in cholesterol-fed Tg rabbits. Atherosclerosis. 2005;179(1):87–95.
23 Berberine activates caspase-9/cytochrome c-mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo. Biomed Pharmacother. 2017;95:18–24.
24 . The effect of alpha-lipoic acid on liver function and metabolic marker in obese patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. IRCMJ. 2018;20(3):e65925–e37.
25 . Effects of dietary α-lipoic acid enantiomers on hepatic fatty acid metabolism in rats. J Funct Foods. 2013;5(1):71–9.
26 . α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase. Diabetologia. 2012;55(6):1824–35.
27 . Anti-obesity and lipid-lowering properties of alpha-lipoic acid. J Hum Nutr Food Sci. 2013;1:1002–8.
28 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8(11):1288–95.
29 . High-density lipoprotein and the acute phase response. Curr Opin Endocrinol Diabetes Obes. 2010;17(2):156–63.
30 . Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin J Am Soc Nephrol. 2009;4(Supplement 1):S56–S63.
31 A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet. 1999;21(4):424–8.